Allergan plc

À propos

Allergan plc (NYSE: AGN) is a bold, global pharmaceutical company. We are focused on developing, manufacturing and commercializing branded pharmaceutical, device, biologic, surgical and regenerative medicine products for patients around the world. We market a portfolio of leading brands and best-in-class products for the central nervous system, eye care, medical aesthetics and dermatology, gastroenterology, women’s health, urology and anti-infective therapeutic categories. We are an industry leader in Open Science, our R&D model, which defines our approach to identifying and developing game-changing ideas and innovation for better patient care. With this approach we have built one of the broadest development pipelines in the pharmaceutical industry with 50+ mid-to-late stage pipeline programs in development. Our Company’s success is powered by our more than 17,000 global colleagues’ commitment to being Bold for Life. Together, we build bridges, power ideas, act fast and drive results for our customers and patients around the world by always doing what is right. With commercial operations in approximately 100 countries, Allergan is committed to working with physicians, healthcare providers and patients to deliver innovative and meaningful treatments that help people around the world live longer, healthier lives every day. For more information, visit Allergan’s website at www.Allergan.com.